Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-3 of 3
Keywords: Hematopoietic cell transplant
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2021) 144 (5): 500–507.
Published Online: 09 March 2021
...Haowen Xiao; Yi Luo; Jimin Shi; Aiyun Jin; Mohamad Mohty; Arnon Nagler; Robert Peter Gale; He Huang Patients receiving a hematopoietic cell transplant are thought to be at increased risk of infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus infectious...
Journal Articles
Iván Murrieta-Álvarez, David P. Steensma, Juan Carlos Olivares-Gazca, Mauricio Olivares-Gazca, Andrés León-Peña, Yahveth Cantero-Fortiz, Yarely Itzayana García-Navarrete, Antonio Cruz-Mora, Alejandro Ruiz-Argüelles, Guillermo José Ruiz-Delgado, Guillermo José Ruiz-Argüelles
Journal:
Acta Haematologica
Acta Haematol (2020) 143 (6): 552–558.
Published Online: 11 February 2020
.... Bor-tezomib (1.75 mg s.c. every week) was administered to those who could afford it. After 4–6 weeks of treatment, patients were offered an outpatient-based hematopoietic cell transplant (HCT). After the recovery of granulocytes following HCT, patients continued indefinitely on thalidomide; those who...
Journal Articles
Journal:
Acta Haematologica
Acta Haematol (2014) 132 (3-4): 331–339.
Published Online: 10 September 2014
... determined. The treatment options include human leukocyte antigen-identical sibling hematopoietic cell transplantation or immunosuppressive therapy, and both require attention to the specific medical and social needs of these adolescents and young adults. Longitudinal surveillance throughout life...